What does CUSIP 45257U108 represent in this 13F holders report?

CUSIP 45257U108 is the security identifier for IMNM - Immunome Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held IMNM - Immunome Inc. - Common Stock in Q2 2023?

35 institutional investors reported IMNM - Immunome Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Immunome Inc. - Common Stock (IMNM)

CUSIP: 45257U108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 109,968,942
Total 13F shares: 1,949,082
Share change: +88,387
Total reported value: $15,421,801
Put/Call ratio: 104%
Price per share: $7.91
Number of holders: 35
Value change: +$698,301
Number of buys: 15
Number of sells: 6

Quarterly Holders Quick Answers

What is CUSIP 45257U108?
CUSIP 45257U108 identifies IMNM - Immunome Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 45257U108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IMNM - Immunome Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Prentice Capital Management, LP	13F	Company	0.39%	431,904	$2,155,201	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	0.34%	373,878	$1,865,652	—	31 Mar 2023	13F
Alpine Global Management, LLC	13F	Company	0.33%	365,971	$1,826,195	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.14%	149,650	$747,000	—	31 Mar 2023	13F
BANK OF MONTREAL /CAN/	13F	Company	0.08%	92,593	$524,076	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	81,213	$405,252	—	31 Mar 2023	13F
Cerity Partners LLC	13F	Company	0.05%	53,347	$266,202	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.04%	41,539	$207,280	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.03%	29,591	$147,659	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.03%	28,900	$144,000	—	31 Mar 2023	13F
ROYAL BANK OF CANADA	13F	Company	0.03%	27,777	$139,000	—	31 Mar 2023	13F
Magnus Financial Group LLC	13F	Company	0.02%	25,759	$128,537	—	31 Mar 2023	13F
Baldwin Investment Management, LLC	13F	Company	0.02%	25,394	$126,716	—	31 Mar 2023	13F
Sterling Investment Advisors, Ltd.	13F	Company	0.02%	21,627	$107,919	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.02%	16,798	$83,822	—	31 Mar 2023	13F
HighTower Advisors, LLC	13F	Company	0.02%	16,818	$83,000	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.01%	15,433	$77,011	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	12,551	$62,629	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.01%	12,130	$60,528	—	31 Mar 2023	13F
Wealth Architects, LLC	13F	Company	0.01%	11,110	$55,439	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.01%	7,705	$38,448	—	31 Mar 2023	13F
SIMPLEX TRADING, LLC	13F	Company	0.01%	6,423	$32,000	—	31 Mar 2023	13F
NATIXIS	13F	Company	0%	3,000	$14,970	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0%	2,940	$14,671	—	31 Mar 2023	13F
MB, LEVIS & ASSOCIATES, LLC	13F	Company	0%	2,373	$11,841	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	1,854	$9,251	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,328	$7,000	—	31 Mar 2023	13F
Newbridge Financial Services Group, Inc.	13F	Company	0%	375	$1,871	—	31 Mar 2023	13F
Farther Finance Advisors, LLC	13F	Company	0%	100	$499	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0%	14	$70	—	31 Mar 2023	13F
Purnanand D. Sarma	3/4/5	President and CEO, Director	— class O/S missing	166,500	—	—	08 Jun 2023	3/4/5
Corleen M. Roche	3/4/5	Chief Financial Officer	— class O/S missing	58,000	—	—	08 Jun 2023	3/4/5
Matthew K. Robinson	3/4/5	Chief Technology Officer	— class O/S missing	58,000	—	—	08 Jun 2023	3/4/5
Dennis H. Giesing	3/4/5	Chief Development Officer	— class O/S missing	50,000	—	—	08 Jun 2023	3/4/5
John L. Lamattina	3/4/5	Director	— class O/S missing	6,500	—	—	08 Jun 2023	3/4/5
Michael Lefenfeld	3/4/5	Director	— class O/S missing	6,500	—	—	08 Jun 2023	3/4/5
Richard A. Baron	3/4/5	Director	— class O/S missing	6,500	—	—	08 Jun 2023	3/4/5
Michael Widlitz	3/4/5	Director	— class O/S missing	3,750	—	—	28 May 2021	3/4/5

Institutional Holders of Immunome Inc. - Common Stock (IMNM) as of Q2 2023

As of 30 Jun 2023, Immunome Inc. - Common Stock (IMNM) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,949,082 shares. The largest 10 holders included Point72 Asset Management, L.P., VANGUARD GROUP INC, Alpine Global Management, LLC, Prentice Capital Management, LP, BANK OF MONTREAL /CAN/, GEODE CAPITAL MANAGEMENT, LLC, Cerity Partners LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and BlackRock Inc.. This page lists 35 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.